These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164 [TBL] [Abstract][Full Text] [Related]
3. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy. De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609 [TBL] [Abstract][Full Text] [Related]
4. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. Martinon F; Michelet C; Peguillet I; Taoufik Y; Lefebvre P; Goujard C; Guillet JG; Delfraissy JF; Lantz O AIDS; 1999 Feb; 13(2):185-94. PubMed ID: 10202824 [TBL] [Abstract][Full Text] [Related]
5. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta. Kumar D; Parato K; Kumar A; Sun E; Cameron DW; Angel JB AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1073-7. PubMed ID: 10461827 [TBL] [Abstract][Full Text] [Related]
6. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy. Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680 [TBL] [Abstract][Full Text] [Related]
7. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART. Wasmuth JC; Nischalke HD; Jütte A; Fätkenheuer G; Salzberger B; Sauerbruch T; Spengler U; Rockstroh JK; Dumoulin FL Antiviral Res; 2004 Mar; 61(3):207-12. PubMed ID: 15168802 [TBL] [Abstract][Full Text] [Related]
8. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943 [TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection. Carter LM; Peters BS; Ellis BA; Wolstencroft RA J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614 [TBL] [Abstract][Full Text] [Related]
11. Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection. Burton CT; Hardy GA; Sullivan AK; Nelson MR; Gazzard B; Gotch FM; Imami N Clin Exp Immunol; 2002 Nov; 130(2):286-92. PubMed ID: 12390317 [TBL] [Abstract][Full Text] [Related]
12. Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Trumpfheller C; Tenner-Racz K; Racz P; Fleischer B; Frosch S Clin Exp Immunol; 1998 Apr; 112(1):92-9. PubMed ID: 9566795 [TBL] [Abstract][Full Text] [Related]
13. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression. Llano A; Barretina J; Gutiérrez A; Clotet B; Esté JA J Virol; 2003 Apr; 77(7):4389-95. PubMed ID: 12634395 [TBL] [Abstract][Full Text] [Related]
15. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. Pinto LA; Williams MS; Dolan MJ; Henkart PA; Shearer GM Eur J Immunol; 2000 Jul; 30(7):2048-55. PubMed ID: 10940894 [TBL] [Abstract][Full Text] [Related]
16. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367 [TBL] [Abstract][Full Text] [Related]
17. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals. Mikawa AY; Tagliavini SA; Costa PI Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633 [TBL] [Abstract][Full Text] [Related]
18. High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome. Benveniste O; Dereuddre-Bosquet N; Clayette P; Leport C; Vildé JL; Dormont D Clin Exp Immunol; 2000 Aug; 121(2):320-3. PubMed ID: 10931148 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes. Creery D; Weiss W; Lim WT; Aziz Z; Angel JB; Kumar A Clin Exp Immunol; 2004 Jul; 137(1):156-65. PubMed ID: 15196257 [TBL] [Abstract][Full Text] [Related]
20. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]